1Study on predictive biomarker of cetuximab in combination with capecitabine plus cisplatin as first line treatment in advanced gastric cancerARTICLES385-389
2Study on concurrent chemotherapy and radiotherapy for locally advanced unresectable(stage Ⅲ) non-small cell lung cancerARTICLES390-395
3Clinical observation of gefitinib as the first line therapy for advanced or metastatic non-small cell lung cancerARTICLES396-400
5Suppression of brain glioma cells expression of HMGA1 by lentivirus-mediated RNAi and its effect on lobaplatin chemosensitivityARTICLES405-409
6Effect of endostar on proliferation and cell cycle of lung cancer microvasculature endothelial cell HPMECARTICLES410-413
7Experimental research about different inhibition of platinum complexes in human hepatocellular carcinoma cell lineARTICLES414-417
8Effects of recombinant human endostatin(endostar) combined of cisplatin on the growth of lung cancer in nude mouseARTICLES418-420
10The study of gemcitabine plus vinorelbine in the patients with triple-negative metastatic breast cancerARTICLES425-428
11A clinical study of lung and esophageal cancer radical surgery with minimally invasive incisionARTICLES429-431
14Relationship of expression of Ang-1, Ang-2 and Tie-2 and angiogenesis in hepatocellular carcinomaARTICLES439-442
15Study of clinical dose distribution on patients with esophagectomy treated by intensity modulated radiation therapyARTICLES443-445
16Dosimetric study of five-field intensity modulated radiotherapy compared with conventional three-dimensional conformal radiotherapy for rectal cancerARTICLES446-449
17Clinical research of advanced gastric cancer treated with docetaxel combined with oxaliplatin and fluorouracilARTICLES450-451
18Clinical research of recombinant human interleukin-11 therapy for chemotherapy induced thrombocytopeniaCLINICAL PRACTICE452-453
19The analysis of the combined therapy on gastric cancer with supraclavicular lymph node metastasesCLINICAL PRACTICE454-456
20Discussion of using hyperthermic peritoneal perfusion chemotherapy and p53 gene therapy for the recurrence patient of primary adenocarcinoma of the seminal vesicles with greater omentum metastasisCLINICAL PRACTICE457-461
